Tag : PDL1

Pharma / Biotech

Selection of the Recommended Phase 2 Dose for Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1.

Newsemia
Related Articles Selection of the Recommended Phase 2 Dose for Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1. Clin Pharmacol Ther. 2020 Jan...
Gastroenterology

Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels

Newsemia
Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels Source link...
Gastroenterology

Molecular alterations and PD-L1 expression in non-ampullary duodenal adenocarcinoma: Associations among clinicopathological, immunophenotypic and molecular features

Newsemia
Molecular alterations and PD-L1 expression in non-ampullary duodenal adenocarcinoma: Associations among clinicopathological, immunophenotypic and molecular features Source link...
Latest News

PD-L1 expressing granulomatous reaction as an on-target mechanism of steroid-refractory immune hepatotoxicity

Newsemia
Black, JR; Goldin, RD; Foxton, M; Marafioti, T; Akarca, AU; Pria, AD; Brock, C; … Pinato, DJ; + view all Black, JR; Goldin, RD; Foxton,...
Dermatology

Concordance of somatic mutation profiles [BRAF, NRAS and TERT] and tumoral PD-L1 in matched primary cutaneous and metastatic melanoma samples.

Newsemia
Related Articles Concordance of somatic mutation profiles [BRAF, NRAS and TERT] and tumoral PD-L1 in matched primary cutaneous and metastatic melanoma samples. Hum Pathol. 2018...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy